Applied Genetic Technologies reported $-16003000 in EBIT for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Applied Genetic Technologies AGTC:US $ -16003000 2.62M
Avrobio Inc AVRO:US $ -32620000 1.24M
Biogen BIIB:US $ 858.6M 171.5M
Bluebird Bio BLUE:US $ -196779000 44.06M
Celldex Therapeutics CLDX:US $ -17324000 3.88M
Cti Biopharma CTIC:US $ -23381000 3.88M
Gilead Sciences GILD:US $ 3883M 1637M
Insmed INSM:US $ -95317000 6.75M
Intercept Pharmaceuticals ICPT:US $ -6218000 6.73M
Life Technologies LIFE:US $ -7728000 2.72M
Regeneron Pharmaceuticals REGN:US $ 1847.2M 1500M
Rigel Pharmaceuticals RIGL:US $ -19785000 6.74M
Ultragenyx Pharmaceutical RARE:US $ -89828000 7.05M